2026-2034年全球神经诊断和监测设备市场规模、份额、趋势和成长分析报告

预计到 2034 年，神经诊断和监测设备的市场规模将从 2025 年的 87.7 亿美元达到 175.5 亿美元，并预计从 2026 年到 2034 年将以 8.01% 的复合年增长率增长。

由于癫痫、帕金森氏症、阿兹海默症和中风等神经系统疾病的盛行率不断上升，全球神经诊断和监测设备市场正经历显着增长。人们对早期诊断和持续监测重要性的认识不断提高，推动了对先进影像和神经监测系统的需求。脑电图 (EEG)、肌电图 (EMG) 和脑部影像设备的技术进步正在提高诊断准确性和改善患者预后。全球医疗保健基础设施的不断改进和老年人口的成长进一步加速了市场成长。

关键成长要素包括医疗费用支出增加、微创诊断工具的普及以及人工智慧分析技术在神经系统评估中的应用。医院和专科诊所正在投资携带式和穿戴式监测设备，以即时追踪患者病情。此外，旨在加深我们对神经退化性疾病理解的研究倡议也推动了对先进诊断平台的需求。已开发地区的政府资助和优惠的还款政策也显着促进了市场成长。

展望未来，数位健康技术和远端监测解决方案的持续创新有望推动市场发展。紧凑型无线神经诊断系统的开发将有助于新兴市场更好地获取相关服务。远端医疗的普及和个人化治疗方案的进步将进一步提升市场需求。随着全球神经系统疾病发病率的持续上升，对精准高效的诊断和监测设备的需求预计将支撑市场的长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球神经学诊断与监测设备市场：依设备类型划分

• 市场分析、洞察与预测
• 脑电图（EEG）系统
• 磁振造影造影（MRI）系统
• 电脑断层扫描器（CT扫描仪）
• 正子断层扫描（PET）系统
• 超音波影像设备
• 其他的

第五章 全球神经学诊断与监测设备市场：依适应症划分

• 市场分析、洞察与预测
• 神经退化性疾病
• 癫痫
• 中风
• 其他的

第六章 全球神经诊断与监测设备市场：依最终使用者划分

• 市场分析、洞察与预测
• 医院和外科中心
• 神经病学中心
• 门诊部
• 诊断检查室和诊断影像中心
• 研究机构和学术机构

第七章 全球神经学诊断与监测设备市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • GE Healthcare
  • Neurosoft
  • Canon Medical Systems Corporation（Canon Inc.）
  • Fujifilm Holding Corporation
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Shimadzu Corporation
  • United Imaging Healthcare Co. Ltd
  • Hologic Inc
  • Esaote SpA

The Neurology Diagnostic and Monitoring Devices Market size is expected to reach USD 17.55 Billion in 2034 from USD 8.77 Billion (2025) growing at a CAGR of 8.01% during 2026-2034.

The Global Neurology Diagnostic and Monitoring Devices Market is experiencing strong growth due to the rising prevalence of neurological disorders such as epilepsy, Parkinson's disease, Alzheimer's disease, and stroke. Increasing awareness regarding early diagnosis and continuous monitoring has driven demand for advanced imaging and neuro-monitoring systems. Technological advancements in EEG, EMG, and brain imaging devices are improving diagnostic accuracy and patient outcomes. Expanding healthcare infrastructure and growing geriatric populations worldwide are further accelerating market expansion.

Key growth drivers include increasing healthcare expenditure, adoption of minimally invasive diagnostic tools, and the integration of AI-based analytics in neurological assessments. Hospitals and specialty clinics are investing in portable and wearable monitoring devices for real-time patient tracking. Additionally, research initiatives focused on understanding neurodegenerative diseases are supporting demand for advanced diagnostic platforms. Government funding and favorable reimbursement policies in developed regions also contribute significantly to market growth.

Looking ahead, the market is expected to benefit from continuous innovation in digital health technologies and remote monitoring solutions. The development of compact, wireless neurodiagnostic systems will enhance accessibility in emerging markets. Growing telemedicine adoption and personalized treatment approaches will further expand demand. As neurological disorders continue to rise globally, the need for accurate and efficient diagnostic and monitoring devices will sustain long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Electroencephalogram (EEG) Systems
• Magnetic Resonance Imaging (MRI) Systems
• Computed Tomography (CT) Scanner
• Position Emission Tomography (PET) System
• Ultrasound Imaging Systems
• Others

By Indication

• Neurodegenerative Disease
• Epilepsy
• Stroke
• Others

By End-user

• Hospitals and Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes

COMPANIES PROFILED

• GE Healthcare, Neurosoft, Canon Medical Systems Corporation Canon Inc, Fujifilm Holding Corporation, Koninklijke Philips NV, Siemens Healthineers AG, Shimadzu Corporation, United Imaging Healthcare Co Ltd, Hologic Inc, Esaote SpA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Electroencephalogram (EEG) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Magnetic Resonance Imaging (MRI) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Computed Tomography (CT) Scanner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Position Emission Tomography (PET) System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Ultrasound Imaging Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Neurodegenerative Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Epilepsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals and Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurology Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Diagnostic Laboratories & Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Research Laboratories & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By Indication
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By Indication
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By Indication
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By Indication
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By Indication
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 GE Healthcare
  • 9.2.2 Neurosoft
  • 9.2.3 Canon Medical Systems Corporation (Canon Inc.)
  • 9.2.4 Fujifilm Holding Corporation
  • 9.2.5 Koninklijke Philips N.V
  • 9.2.6 Siemens Healthineers AG
  • 9.2.7 Shimadzu Corporation
  • 9.2.8 United Imaging Healthcare Co. Ltd
  • 9.2.9 Hologic Inc
  • 9.2.10 Esaote SpA